For the Inventor, By the Inventor

Enter inventor name

Fort Collins, CO, United States of America

David W Osborne

USPTO Granted Patents = 41 (Patent Applications = 30)

CIPO Patents = 6 (Patent Applications = 2)

EPO Patents = 3 (Patent Applications = 17)

Average Co-Inventor Count = 1.3

ph-index = 13

Forward Citations = 387(Granted Patents)

Location History:

Santa Rosa, CA (US) (2007 - 2012)
Fort Collins, CO (US) (2002 - 2024)

Company Filing History:

Arcutis Biotherapeutics, Inc.

Dow Pharmaceutical Sciences, Inc.

Axrix Laboratories, Inc.

Atrix Laboratories, Inc.

Amderma Pharmaceuticals, LLC

Years Active: 2002-2025

Loading Chart...

Loading Chart...

Loading Chart...

Areas of Expertise:

Pharmaceutical Compositions

Deep Dermal Drug Delivery

Topical Roflumilast

Crystal Growth Inhibition

Pharmacokinetic Profile

Skin Penetration Enhancing Systems

Corticosteroid Compositions

Azithromycin Treatments

Controlled Release Formulations

Topical Acne Medications

UV-Induced Skin Damage Protection

Aerosol Formulations

41 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12458652 - Pharmaceutical compositions of spironolactone for deep dermal drug delivery (2025-11-04),

2. 12453721 - Topical roflumilast aerosol foams (2025-10-28),

3. 12390453 - Method for reducing side effects from administration of phosphodiesterase-4 inhibitors (2025-08-19),

4. 12336983 - Inhibition of crystal growth of roflumilast (2025-06-24),

5. 12329751 - Topical roflumilast formulation having antifungal properties (2025-06-17),

6. 12310956 - Topical roflumilast formulation having improved delivery and plasma half-life (2025-05-27),

7. 12257242 - Inhibition of crystal growth of roflumilast (2025-03-25),

8. 12220409 - Roflumilast formulations with an improved pharmacokinetic profile (2025-02-11),

9. 12144802 - Pharmaceutical compositions of roflumilast and solvents capable of dissolving high amounts of the drug (2024-11-19),

10. 12083122 - Laureth-4 containing topical formulations (2024-09-10),

11. 12053481 - Compositions and methods for deep dermal drug delivery (2024-08-06),

12. 12042558 - Method and formulation for improving roflumilast skin penetration lag time (2024-07-23),

13. 12042487 - Method for reducing side effects from administration of phosphodiesterase-4 inhibitors (2024-07-23),

14. 12016848 - Roflumilast formulations with an improved pharmacokinetic profile (2024-06-25),

15. 12011437 - Roflumilast formulations with an improved pharmacokinetic profile (2024-06-18),

Title: The Innovative Journey of David W Osborne

Introduction: David W Osborne, a talented inventor hailing from Fort Collins, CO (US), has made significant contributions to the world of technology through his groundbreaking innovations.

Latest Patents: David's latest patents focus on renewable energy solutions, with a series of inventions aimed at enhancing the efficiency of solar panels and wind turbines.

Career Highlights: With a background in mechanical engineering, David has spent over two decades working in the renewable energy sector. His career highlights include the development of a revolutionary energy storage system that has garnered international acclaim.

Collaborations: Throughout his career, David has collaborated with leading research institutions and universities to further his innovative projects. His partnerships have led to the creation of cutting-edge technologies that are shaping the future of sustainable energy.

Conclusion: David W Osborne's passion for innovation and commitment to sustainability have established him as a pioneering figure in the field of renewable energy. His inventive spirit continues to drive progress and inspire future generations of inventors.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…